166 related articles for article (PubMed ID: 17071132)
1. Glucose transporter type 1 expression are associated with poor prognosis in patients with salivary gland tumors.
Mori Y; Tsukinoki K; Yasuda M; Miyazawa M; Kaneko A; Watanabe Y
Oral Oncol; 2007 Jul; 43(6):563-9. PubMed ID: 17071132
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases.
Miyabe S; Okabe M; Nagatsuka H; Hasegawa Y; Inagaki A; Ijichi K; Nagai N; Eimoto T; Yokoi M; Shimozato K; Inagaki H
J Oral Maxillofac Surg; 2009 Jul; 67(7):1432-41. PubMed ID: 19531414
[TBL] [Abstract][Full Text] [Related]
3. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
[TBL] [Abstract][Full Text] [Related]
4. Correlation of human Bub1 expression with tumor-proliferating activity in salivary gland tumors.
Shigeishi H; Yoneda S; Taki M; Nobumori T; Ohta K; Higashikawa K; Yasui W; Kamata N
Oncol Rep; 2006 Apr; 15(4):933-8. PubMed ID: 16525682
[TBL] [Abstract][Full Text] [Related]
5. Salivary gland tumors: a 10-year retrospective study of survival in relation to size, histopathological examination of the tumor, and nodal status.
Dorairajan N; Periyasamy S; Muthayya P; Manikandan R; Srinivasan T; Siddharth D
Int Surg; 2004; 89(3):140-9. PubMed ID: 15521250
[TBL] [Abstract][Full Text] [Related]
6. Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: correlation with vascular endothelial growth factor, microvessel density, and clinical outcome.
Shi L; Chen XM; Wang L; Zhang L; Chen Z
Cancer; 2007 Apr; 109(8):1523-31. PubMed ID: 17342767
[TBL] [Abstract][Full Text] [Related]
7. Expression of TPX2 in salivary gland carcinomas.
Shigeishi H; Ohta K; Hiraoka M; Fujimoto S; Minami M; Higashikawa K; Kamata N
Oncol Rep; 2009 Feb; 21(2):341-4. PubMed ID: 19148505
[TBL] [Abstract][Full Text] [Related]
8. [Expression of glucose transporter 1 in gastric carcinoma and metastatic lymph nodes and its association with prognosis].
Wei B; Chen L; Li J
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):277-80. PubMed ID: 19434538
[TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix metalloproteinase inducer expression in salivary gland tumors: a correlation with microvessel density.
Huang ZQ; Chen WL; Li HG; Li JS; Xu ZY; Lin ZY
J Craniofac Surg; 2010 Nov; 21(6):1855-60. PubMed ID: 21119439
[TBL] [Abstract][Full Text] [Related]
10. [Expression of glucose transporter-1 and its correlation with basic fibroblast growth factor and proliferating cell nuclear antigen in epithelial ovarian neoplasm].
Zhao SJ; Liu JY; Ren FR; Feng YJ
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):264-8. PubMed ID: 15924676
[TBL] [Abstract][Full Text] [Related]
11. Expression of facilitative glucose transporters in gastric tumors.
Noguchi Y; Marat D; Saito A; Yoshikawa T; Doi C; Fukuzawa K; Tsuburaya A; Satoh S; Ito T
Hepatogastroenterology; 1999; 46(28):2683-9. PubMed ID: 10522065
[TBL] [Abstract][Full Text] [Related]
12. High expression level of geminin predicts a poor clinical outcome in salivary gland carcinomas.
Yamazaki M; Fujii S; Murata Y; Hayashi R; Ochiai A
Histopathology; 2010 Jun; 56(7):883-92. PubMed ID: 20497246
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of Wnt pathway components in human salivary gland tumors.
Queimado L; Obeso D; Hatfield MD; Yang Y; Thompson DM; Reis AM
Arch Otolaryngol Head Neck Surg; 2008 Jan; 134(1):94-101. PubMed ID: 18209144
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of glucose transporter 1 expression in patients with hypopharyngeal carcinoma.
Mineta H; Miura K; Takebayashi S; Misawa K; Araki K; Misawa Y; Ueda Y
Anticancer Res; 2002; 22(6B):3489-94. PubMed ID: 12552944
[TBL] [Abstract][Full Text] [Related]
15. [Expression of glucose transporter 1 in human laryngeal squamous cell carcinoma and its clinical significance].
Jiang J; Hu G; Wu W; Kang N
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Dec; 24(24):1119-22. PubMed ID: 21395180
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor expression correlates with cyclooxygenase-2 pathway in human salivary gland tumors.
Aoki T; Tsukinoki K; Kurabayashi H; Sasaki M; Yasuda M; Ota Y; Watanabe Y; Kaneko A
Oral Oncol; 2006 Jan; 42(1):51-6. PubMed ID: 16139560
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma.
Zhang CY; Mao L; Li L; Tian Z; Zhou XJ; Zhang ZY; Li J
Cancer; 2007 Jul; 110(1):87-95. PubMed ID: 17520682
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.
Williams MD; Roberts D; Blumenschein GR; Temam S; Kies MS; Rosenthal DI; Weber RS; El-Naggar AK
Am J Surg Pathol; 2007 Nov; 31(11):1645-52. PubMed ID: 18059220
[TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor in salivary gland carcinomas correlates with lymph node metastasis.
Lequerica-Fernández P; Astudillo A; de Vicente JC
Anticancer Res; 2007; 27(5B):3661-6. PubMed ID: 17972532
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
